WallStreetZenWallStreetZen

NYSE: RMD
Resmed Inc Stock Ownership - Who owns Resmed?

Insider buying vs selling

Have Resmed Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Brett SandercockChief Financial Officer2024-06-101,000$209.81
$209.81kSell
Michael J. FarrellChief Executive Officer2024-06-0714,683$84.98
$1.25MBuy
Michael J. FarrellChief Executive Officer2024-06-0714,683$211.66
$3.11MSell
Michael J. RiderGlobal General Counsel2024-06-04267$206.33
$55.09kSell
Witte Jan DeDirector2024-05-15360$218.29
$78.58kSell
Witte Jan DeDirector2024-05-15360$218.29
$78.58kSell
Witte Jan DeDirector2024-05-15360$218.29
$78.58kSell
Brett SandercockChief Financial Officer2024-05-0812,000$101.64
$1.22MBuy
Brett SandercockChief Financial Officer2024-05-0813,000$211.37
$2.75MSell
Michael J. FarrellChief Executive Officer2024-05-0713,507$84.98
$1.15MBuy

1 of 6

RMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RMD insiders and whales buy or sell their stock.

RMD Shareholders

What type of owners hold Resmed Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc12.10%17,769,766$3.66BInstitution
Blackrock Inc8.30%12,194,535$2.51BInstitution
State Street Corp4.29%6,299,015$1.30BInstitution
Bank Of New York Mellon Corp2.60%3,813,119$784.85MInstitution
Geode Capital Management LLC2.33%3,423,177$704.59MInstitution
Morgan Stanley1.32%1,938,132$398.93MInstitution
Invesco Ltd1.27%1,870,615$385.03MInstitution
Christopher G. Roberts1.16%1,700,337$349.98MInsider
Fmr LLC1.10%1,614,997$332.41MInstitution
Northern Trust Corp0.97%1,422,126$292.72MInstitution

1 of 3

RMD vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RMD55.32%4.26%Net SellingNet Selling
WST92.82%3.68%Net BuyingNet Buying
COO93.32%0.86%Net Selling
BAX84.53%15.47%Net SellingNet Selling
HOLX86.52%13.48%Net SellingNet Selling

Resmed Stock Ownership FAQ

Who owns Resmed?

Resmed (NYSE: RMD) is owned by 55.32% institutional shareholders, 4.26% Resmed insiders, and 40.42% retail investors. Christopher G. Roberts is the largest individual Resmed shareholder, owning 1.70M shares representing 1.16% of the company. Christopher G. Roberts's Resmed shares are currently valued at $309.80M.

If you're new to stock investing, here's how to buy Resmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.